Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick J Clifton-Bligh

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Endocrine-Related Cancer|December 10, 2024
Mechanisms of resistance to RET-directed therapiesRoderick J Clifton-Bligh
Reviews in Endocrine & Metabolic Disorders|January 13, 2023
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancyRoderick J Clifton-Bligh
Molecular and Cellular Endocrinology|March 10, 2010
Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approachMarianne S Elston, Roderick J Clifton-Bligh
Future Oncology (London, England)|July 9, 2016
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectivesEmma Scott, Diana Learoyd, Roderick J Clifton-Bligh
Endocrinology, Diabetes & Metabolism Case Reports|August 24, 2022
Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasiaAdam I Kaplan, Catherine Luxford, Roderick J Clifton-Bligh
BMJ (Clinical Research Ed.)|May 30, 2014
Investigating hypophosphataemiaPaul Glendenning, Damon A Bell, Roderick J Clifton-Bligh
Endocrine-Related Cancer|August 15, 2015
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5Diana E Benn, Bruce G Robinson, Roderick J Clifton-Bligh
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 16, 2019
Metabolomics in the Diagnosis of Pheochromocytoma and ParagangliomaTrisha Dwight, Edward Kim, Talia Novos, et al.
Clinical Endocrinology|May 22, 2021
Papillary thyroid microcarcinoma: Is active surveillance always enough?Rosie Sutherland, Venessa Tsang, Roderick J Clifton-Bligh, et al.
The American Journal of Surgical Pathology|July 15, 2011
"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTsAnthony J Gill, Angela Chou, Ricardo E Vilain, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Endocrine-Related Cancer|December 10, 2024
Mechanisms of resistance to RET-directed therapiesRoderick J Clifton-Bligh
Reviews in Endocrine & Metabolic Disorders|January 13, 2023
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancyRoderick J Clifton-Bligh
Molecular and Cellular Endocrinology|March 10, 2010
Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approachMarianne S Elston, Roderick J Clifton-Bligh
Future Oncology (London, England)|July 9, 2016
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectivesEmma Scott, Diana Learoyd, Roderick J Clifton-Bligh
Endocrinology, Diabetes & Metabolism Case Reports|August 24, 2022
Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasiaAdam I Kaplan, Catherine Luxford, Roderick J Clifton-Bligh
BMJ (Clinical Research Ed.)|May 30, 2014
Investigating hypophosphataemiaPaul Glendenning, Damon A Bell, Roderick J Clifton-Bligh
Endocrine-Related Cancer|August 15, 2015
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5Diana E Benn, Bruce G Robinson, Roderick J Clifton-Bligh
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 16, 2019
Metabolomics in the Diagnosis of Pheochromocytoma and ParagangliomaTrisha Dwight, Edward Kim, Talia Novos, et al.
Clinical Endocrinology|May 22, 2021
Papillary thyroid microcarcinoma: Is active surveillance always enough?Rosie Sutherland, Venessa Tsang, Roderick J Clifton-Bligh, et al.
The American Journal of Surgical Pathology|July 15, 2011
"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTsAnthony J Gill, Angela Chou, Ricardo E Vilain, et al.
Pageof 14